Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CCL2 antibody

CCL2 Reactivity: Human ELISA, LMNX Host: Mouse Monoclonal OTI2H5 unconjugated
Catalog No. ABIN2725644
  • Target See all CCL2 Antibodies
    CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
    Reactivity
    • 98
    • 61
    • 59
    • 18
    • 18
    • 18
    • 16
    • 9
    • 3
    • 3
    • 2
    • 1
    • 1
    Human
    Host
    • 119
    • 55
    • 8
    • 7
    • 3
    • 2
    • 2
    Mouse
    Clonality
    • 135
    • 61
    Monoclonal
    Conjugate
    • 109
    • 33
    • 14
    • 7
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    This CCL2 antibody is un-conjugated
    Application
    • 138
    • 68
    • 56
    • 28
    • 26
    • 25
    • 24
    • 18
    • 15
    • 13
    • 13
    • 13
    • 12
    • 11
    • 11
    • 6
    • 2
    • 1
    • 1
    • 1
    ELISA, Luminex Assay (LMNX)
    Immunogen
    Purified recombinant protein of human MCP-1 (NP_002973) produced in HEK293T cell.
    Clone
    OTI2H5
    Isotype
    IgG2a
    Top Product
    Discover our top product CCL2 Primary Antibody
  • Application Notes
    ELISA,LMNX
    Restrictions
    For Research Use only
  • Concentration
    0.5 mg/mL
  • Target
    CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
    Alternative Name
    MCP-1 (CCL2 Products)
    Synonyms
    GDCF-2 antibody, HC11 antibody, HSMCR30 antibody, MCAF antibody, MCP-1 antibody, MCP1 antibody, SCYA2 antibody, SMC-CF antibody, AI323594 antibody, JE antibody, Scya2 antibody, Sigje antibody, MCP-1A antibody, MCP1A antibody, C-C motif chemokine ligand 2 antibody, chemokine (C-C motif) ligand 2 antibody, C-C motif chemokine 2 antibody, CCL2 antibody, Ccl2 antibody, LOC101120093 antibody
    NCBI Accession
    NM_002982
    HGNC
    6347
    Pathways
    Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, ER-Nucleus Signaling, Unfolded Protein Response, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
You are here:
Support